Published in Eur J Cancer on December 23, 2010
Cancer cachexia--pathophysiology and management. J Gastroenterol (2013) 1.20
The use of herbal medicines by people with cancer: a cross-sectional survey. Br J Cancer (2011) 0.99
Gambogic acid synergistically potentiates cisplatin-induced apoptosis in non-small-cell lung cancer through suppressing NF-κB and MAPK/HO-1 signalling. Br J Cancer (2013) 0.99
Cancer cachexia, mechanism and treatment. World J Gastrointest Oncol (2015) 0.96
Hydrophobic flavonoids from Scutellaria baicalensis induce colorectal cancer cell apoptosis through a mitochondrial-mediated pathway. Int J Oncol (2013) 0.95
Traditional Chinese medicine in the prevention and treatment of cancer and cancer metastasis. Oncol Lett (2015) 0.88
Evaluation of effectiveness of herbal medication in cancer care: a review study. Iran J Cancer Prev (2012) 0.83
Effect of Sipjeondaebo-tang on cancer-induced anorexia and cachexia in CT-26 tumor-bearing mice. Mediators Inflamm (2014) 0.82
Edible mushrooms: improving human health and promoting quality life. Int J Microbiol (2015) 0.82
Antiangiogenic activity and pharmacogenomics of medicinal plants from traditional korean medicine. Evid Based Complement Alternat Med (2013) 0.82
Huaier Extract Induces Autophagic Cell Death by Inhibiting the mTOR/S6K Pathway in Breast Cancer Cells. PLoS One (2015) 0.81
Safety surveillance of traditional Chinese medicine: current and future. Drug Saf (2015) 0.80
The selective cytotoxic anti-cancer properties and proteomic analysis of Trigonella Foenum-Graecum. BMC Complement Altern Med (2014) 0.79
Isolation and chemopreventive evaluation of novel naphthoquinone compounds from Alkanna tinctoria. Anticancer Drugs (2013) 0.78
Downregulation of phosphatase of regenerating liver-3 is involved in the inhibition of proliferation and apoptosis induced by emodin in the SGC-7901 human gastric carcinoma cell line. Exp Ther Med (2012) 0.78
Application of transcriptomics in Chinese herbal medicine studies. J Tradit Complement Med (2012) 0.76
The translational aspect of complementary and alternative medicine for cancer with particular emphasis on Kampo. Front Pharmacol (2015) 0.75
Glycyrrhetinic Acid Induces Apoptosis in Leukemic HL60 Cells Through Upregulating of CD95/ CD178. Int J Mol Cell Med (2014) 0.75
Emerging roles of mistletoes in malignancy management. 3 Biotech (2013) 0.75
Arum Palaestinum with isovanillin, linolenic acid and β-sitosterol inhibits prostate cancer spheroids and reduces the growth rate of prostate tumors in mice. BMC Complement Altern Med (2015) 0.75
Bitter melon extract inhibits breast cancer growth in preclinical model by inducing autophagic cell death. Oncotarget (2017) 0.75
Complete remission after treatment of acute promyelocytic leukemia with arsenic trioxide. N Engl J Med (1998) 6.83
Use of arsenic trioxide (As2O3) in the treatment of acute promyelocytic leukemia (APL): II. Clinical efficacy and pharmacokinetics in relapsed patients. Blood (1997) 4.78
Use of complementary and alternative medicine in cancer patients: a European survey. Ann Oncol (2005) 3.98
Clinical and biologic activity of an estrogenic herbal combination (PC-SPES) in prostate cancer. N Engl J Med (1998) 3.47
The spontaneous regression of cancer. A review of cases from 1900 to 1987. Acta Oncol (1990) 2.08
Urothelial malignant disease and Chinese herbal nephropathy. Lancet (2001) 1.73
Clinical effects of oral green tea extracts in four patients with low grade B-cell malignancies. Leuk Res (2005) 1.73
Arsenic trioxide, a therapeutic agent for APL. Oncogene (2001) 1.72
Case reports and case series from Lancet had significant impact on medical literature. J Clin Epidemiol (2005) 1.57
The use of complementary and alternative medicine among Chinese women with breast cancer. J Altern Complement Med (2008) 1.51
A population-based study of prevalence of complementary methods use by cancer survivors: a report from the American Cancer Society's studies of cancer survivors. Cancer (2008) 1.39
Herbal/hormonal dietary supplement possibly associated with prostate cancer progression. Clin Cancer Res (2008) 1.39
Differences in perceived risks and benefits of herbal, over-the-counter conventional, and prescribed conventional, medicines, and the implications of this for the safe and effective use of herbal products. Complement Ther Med (2006) 1.00
Effectiveness of the herbal medicine daikenchuto for radiation-induced enteritis. J Altern Complement Med (2008) 0.96
Urothelial malignancy in nephropathy due to Chinese herbs. Lancet (1994) 0.94
Arsenic and old myths. R I Med (1994) 0.94
Intraoperative haemorrhage associated with the use of extract of Saw Palmetto herb: a case report and review of literature. J Intern Med (2001) 0.93
Delicious poison: arsenic trioxide for the treatment of leukemia. Blood (1997) 0.93
Survey of cancer researchers regarding complementary and alternative medicine. J Soc Integr Oncol (2008) 0.92
Hypereosinophilia induced by high-dose intratumoral and peritumoral mistletoe application to a patient with pancreatic carcinoma. J Altern Complement Med (2000) 0.91
Chinese herbs nephropathy and renal pelvic carcinoma. Nephrol Dial Transplant (1995) 0.88
Regression of hepatocellular carcinoma spontaneous or herbal medicine related? Am J Chin Med (2004) 0.86
Drug interaction between complementary herbal medicines and gefitinib. J Thorac Oncol (2008) 0.86
Silymarine during maintenance therapy of acute promyelocytic leukemia. Haematologica (1994) 0.84
Are immune responses pivotal to cancer patient's long term survival? Two clinical case-study reports on the effects of Morinda citrifolia (Noni). Hawaii Med J (2004) 0.84
Invasive urothelial carcinoma after exposure to Chinese herbal medicine containing aristolochic acid may occur without severe renal failure. Nephrol Dial Transplant (2003) 0.84
Sustained complete remission of CLL associated with the use of a Chinese herbal extract: case report and mechanistic analysis. Leuk Res (2003) 0.84
Hemorrhage after the preoperative use of complementary and alternative medicines. AANA J (2000) 0.84
Role of herbal compounds (PC-SPES) in hormone-refractory prostate cancer: two case reports. J Altern Complement Med (2000) 0.83
The effect of a traditional Chinese prescription for a case of lung carcinoma. J Altern Complement Med (2000) 0.83
The effects of PC-Spes on chemosensitive and chemoresistant head and neck cancer cells and primary mucosal keratinocytes. Oncol Rep (2009) 0.83
Regression of squamous cell carcinoma of the lung by Chinese herbal medicine: a case with an 8-year follow-up. Lung Cancer (2004) 0.82
Death from metastatic basal cell carcinoma: herbal remedy or just unlucky? J Plast Reconstr Aesthet Surg (2008) 0.82
Therapeutic use of mistletoe for CD30+ cutaneous lymphoproliferative disorder/lymphomatoid papulosis. J Eur Acad Dermatol Venereol (2007) 0.81
Phase I trial of PC-Spes2 in advanced hormone refractory prostate cancer. Oncol Rep (2008) 0.81
Successful treatment of metastatic malignant melanoma with Viscum album extract (Iscador M). J Altern Complement Med (2007) 0.80
Mistletoe in conventional oncological practice: exemplary cases. Integr Cancer Ther (2008) 0.80
Efficacy of Nyoshinsan/TJ-67, a traditional herbal medicine, for menopausal symtoms following surgery and adjuvant chemotherapy for premenopausal breast cancer. Int J Clin Oncol (2008) 0.79
Phytoestrogen supplementation: a case report of male breast cancer. Eur J Cancer Prev (2004) 0.77
A hidden cause of hypokalemic paralysis in a patient with prostate cancer. Support Care Cancer (2004) 0.77
Severe bone marrow depression induced by an anticancer herb Cantharanthus roseus. J Toxicol Clin Toxicol (2004) 0.77
Pre-operative hepatitis in a woman treated with Chinese medicines. Anaesthesia (2003) 0.77
Pulmonary embolus related to PC-SPES use in a patient with PSA recurrence after radical prostatectomy. Urology (2002) 0.77
Severe reversible bone marrow suppression induced by Selaginella doederleinii. J Toxicol Clin Toxicol (2001) 0.77
Survey of complementary and alternative medicine practitioners regarding cancer management and research. J Soc Integr Oncol (2009) 0.77
Disseminated intravascular coagulation and PC-SPES: a case report and literature review. Can J Urol (2001) 0.77
Alternative medicine in gynecologic oncology: A case report. Gynecol Oncol (2000) 0.77
Use of PC-SPES, a commercially available supplement for prostate cancer, in a patient with hormone-naive disease. Urology (1999) 0.77
Unique aspects of herbal whole system research. Explore (NY) (2009) 0.77
Long-term survival of a patient with widespread metastases from Barrett's adenocarcinoma. Eur J Surg Oncol (2001) 0.76
Regression of gastric large B-Cell lymphoma accompanied by a florid lymphoma-like T-cell reaction: immunomodulatory effect of Ganoderma lucidum (Lingzhi)? Int J Surg Pathol (2007) 0.76
Delayed-type hypersensitivity reaction with iscador M given in combination with cytotoxic chemotherapy. J Clin Oncol (2004) 0.76
Chinese herbal remedies and radiotherapy. Clin Oncol (R Coll Radiol) (2002) 0.76
Remission of hormone-refractory prostate cancer attributed to Essiac. Can J Urol (2005) 0.76
Atypical teratoid/rhabdoid tumor case report: treatment with surgical excision, radiation therapy, and alternative medicines. J Neurooncol (2005) 0.76
The National Cancer Institute best case series program: a summary of cases of cancer patients treated with unconventional therapies in India. Integr Cancer Ther (2013) 2.12
Research-design issues in cancer-symptom-management trials using complementary and alternative medicine: lessons from the National Cancer Institute Community Clinical Oncology Program experience. J Clin Oncol (2005) 1.19
Adverse events with non-anesthesiologist administration of propofol: what you see is what you get but getting (the right standard monitors) is how you see. Endoscopy (2016) 1.07
Preclinical and phase I clinical trial of blockade of IL-15 using Mikbeta1 monoclonal antibody in T cell large granular lymphocyte leukemia. Proc Natl Acad Sci U S A (2005) 1.06
Exceptional disease courses after the use of CAM: selection, registration, medical assessment, and research. an international perspective. J Altern Complement Med (2006) 0.94
Survey of cancer researchers regarding complementary and alternative medicine. J Soc Integr Oncol (2008) 0.92
Physical activity in patients who are severely mentally ill: feasibility of assessment for clinical and research applications. Arch Psychiatr Nurs (2006) 0.92
Systematic review: generating evidence-based guidelines on the concurrent use of dietary antioxidants and chemotherapy or radiotherapy. Cancer Invest (2011) 0.84
The Role of Grape Seed Extract in the Treatment of Chemo/Radiotherapy Induced Toxicity: A Systematic Review of Preclinical Studies. Nutr Cancer (2015) 0.79
Survey of complementary and alternative medicine practitioners regarding cancer management and research. J Soc Integr Oncol (2009) 0.77
National Cancer Institute Best Case Series program. Integr Cancer Ther (2009) 0.76
Proceedings of the Indo-U.S. bilateral workshop on accelerating botanicals/biologics agent development research for cancer chemoprevention, treatment, and survival. Cancer Med (2013) 0.76
Asian therapies for cancer--coming of age. J Altern Complement Med (2002) 0.76
Design of testis cancer trials: who knows best? J Clin Oncol (2012) 0.75
Lay persons' versus psychologists' judgments of psychologically aggressive actions by a husband and wife. J Interpers Violence (2004) 0.75
Phosphorus addition reverses the positive effect of zebra mussels (Dreissena polymorpha) on the toxic cyanobacterium, Microcystis aeruginosa. Water Res (2012) 0.75